Olanzapine as long-term adjunctive therapy in treatment-resistant bipolar disorder

Journal of Clinical Psychopharmacology

Volumn 21, Issue 5, 2001, Pages 469-473

  Vieta, Eduard ^a,f   Reinares, María ^b   Corbella, Bàrbara ^a   Benabarre, Antoni ^a   Gilaberte, Inmaculada ^c   Colom, Francesc ^b   Martínez Arán, Anabel ^b   Gastó, Cristóbal ^a   Tohen, Mauricio ^d,e  

^a UNIVERSITY OF BARCELONA   (Spain)

^b INSTITUT D INVESTIGACIONS BIOMÈDIQUES AUGUST PI I SUNYER IDIBAPS   (Spain)

^c ELI LILLY AND COMPANY   (Spain)

^d MCLEAN HOSPITAL   (United States)

^e ELI LILLY AND COMPANY   (United States)

^f HOSPITAL CLÍNIC   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

BENZODIAZEPINE DERIVATIVE; CARBAMAZEPINE; CHOLINERGIC RECEPTOR BLOCKING AGENT; CLONAZEPAM; DISULFIRAM; GABAPENTIN; LAMOTRIGINE; LITHIUM; MOOD STABILIZER; NEUROLEPTIC AGENT; OLANZAPINE; PSYCHOTROPIC AGENT; RISPERIDONE; SEROTONIN UPTAKE INHIBITOR; TRICYCLIC ANTIDEPRESSANT AGENT; UNCLASSIFIED DRUG; VALPROIC ACID; VENLAFAXINE;

ADJUVANT CHEMOTHERAPY; ADULT; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DEPRESSION; DOSE CALCULATION; DRUG EFFICACY; DRUG INDUCED DISEASE; FEMALE; HOSPITALIZATION; HUMAN; LONG TERM CARE; MALE; MANIA; MANIC DEPRESSIVE PSYCHOSIS; MOOD; PRIORITY JOURNAL; PSYCHOPHARMACOTHERAPY; RECURRENT DISEASE; RELAPSE; SOMNOLENCE; SYMPTOM; TREATMENT FAILURE; WEIGHT GAIN;

ADULT; ANTIPSYCHOTIC AGENTS; BENZODIAZEPINES; BIPOLAR DISORDER; DISORDERS OF EXCESSIVE SOMNOLENCE; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG RESISTANCE; DRUG THERAPY, COMBINATION; FEMALE; HOSPITALIZATION; HUMANS; MALE; MIDDLE AGED; PIRENZEPINE; RECURRENCE; TIME FACTORS; TREATMENT OUTCOME; WEIGHT GAIN;

EID: 0034790651     PISSN: 02710749     EISSN: None     Source Type: Journal    
DOI: 10.1097/00004714-200110000-00002     Document Type: Article

References (14)

1. The role of complex combination therapy in the treatment of refractory bipolar illness
2. Chronic neuroleptic use in manic-depressive illness
3. A meta-analysis of the use of typical antipsychotic agents in bipolar disorder
4. Anticonvulsants and antipsychotics in the treatment of bipolar disorder
5. Antipsychotics agents in bipolar disorder
6. Clinical outcome in a randomized 1-year trial of clozapine versus treatment as usual for patients with treatment resistant illness and a history of mania
7. Treatment of refractory rapid cycling bipolar disorder with risperidone
8. Risperidone in the treatment of mania
9. Olanzapine versus placebo in the treatment of acute mania
10. Olanzapine in the treatment of mania: A placebo-controlled four-week study
11. Long-term olanzapine treatment of mania: Improvement in mood symptoms and cognitive function
12. Modification of the clinical global impressions (CGI) scale for use in bipolar illness (BP): The CGI-BP
13. Randomized controlled trials and naturalistic data: Time for a change?
14. Olanzapine in treatment-resistant bipolar disorder